R Mang, T Ruzicka, H Stege. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acrodermatitis/drug therapyAntibodies, Monoclonal/therapeutic useDermatologic Agents/therapeutic useHumansInfliximabMaleMiddle AgedNeoplasm Proteins/therapeutic useReceptors, Tumor Necrosis Factor, Type IITreatment OutcomeTumor Necrosis Factor Decoy Receptors
Substances: See more » Antibodies, MonoclonalDermatologic AgentsNeoplasm ProteinsReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor Decoy ReceptorsInfliximab
Year: 2004 PMID: 14996123 DOI: 10.1111/j.1365-2133.2003.05761.x
Source DB: PubMed Journal: Br J Dermatol ISSN: 0007-0963 Impact factor: 9.302